Variant II Hemoglobin A1C Program with Models 270-2101NU

FDA 510(k) K070452 · Bio-Rad Laboratories, Inc.

Substantially Equivalent

510(k) numberK070452

Submission

Device name
Variant II Hemoglobin A1C Program with Models 270-2101NU
Applicant
Bio-Rad Laboratories, Inc.
Hercules, CA, US
Received
February 16, 2007
Decision date
May 7, 2007
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
LCP – Assay, Glycosylated Hemoglobin
Device class
Class II (moderate risk)
Regulation
21 CFR 864.7470
Specialty
Hematology

Other 510(k)s with product code LCP

510(k)DeviceApplicantDecision
K221326Nova Allegro HbA1c Assay, Nova Allegro AnalyzerLCP · Dual Track Nova Biomedical Corporation11/22/2024SE
K231465Q-Pad Test SystemLCP · Traditional Qurasense12/06/2023SE
K214117Afinion™ HbA1c, Afinion™ 2 and Alere Afinion™ AS100 AnalyzerLCP · Dual Track Abbott Diagnostics Technologies AS09/27/2023SE
K192987Aina HbA1c Monitoring System 2LCP · Traditional Jana Care, Inc.03/26/2020SE
K192369PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test KitLCP · Traditional Ixensor Co, Ltd.10/29/2019SE
K183230OneDraw A1C Test SystemLCP · Traditional Drawbridge Health, Inc.08/15/2019SE
K181915PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test KitLCP · Traditional Ixensor Co, Ltd.04/12/2019SE
K180509Quo-Test A1c SystemLCP · Dual Track Ekf-Diagnostic GmbH02/16/2019SE
K173127skyla Hi Hemoglobin A1c System (skyla Hi Analyzer and skyla Hi Hemoglobin A 1 c Reagent…LCP · Traditional Skyla Corporation H.S.P.B09/25/2018SE
K170623ACE Hemoglobin A1c (HbA1c) ReagentLCP · Traditional Alfa Wassermann Diagnostic Technologies, LLC02/27/2018SE

More from Alfa Wassermann Diagnostic Technologies, LLC

510(k)DeviceDecision
K183446BioPlex 2200 Lyme TotalLSR · Traditional 03/12/2019SE
K181661QXDx BCR-ABL %IS Kit for use on the QXDx AutoDG ddPCR SystemOYX · Traditional 02/13/2019SE
K180577BioPlex 2200 25-OH Vitamin D KitMRG · Traditional 06/22/2018SE
K171664Hemoglobin Variants System on Newborn Hemoglobin System with GDM and HbReview SoftwareGKA · Special 09/13/2017SE
K170509BioPlex 2200 ToRC IgM, BioPlex 2200 ToRC IgM Calibrator Set, BioPlex 2200 ToRC IgM…PUQ · Traditional 05/19/2017SE
K170413BioPlex 2200 Syphilis Total & RPR, BioPlex 2200 Syphilis Total & RPR Calibrator Set…LIP · Traditional 05/11/2017SE
K163015Liquichek Tumor Marker Control-Level 1; Liquichek Tumor Marker Control-Level 2…JJY · Traditional 01/10/2017SE
K161687D-10 Hemoglobin A1c ProgramPDJ · Traditional 10/14/2016SE
K152679Amplichek I, Negative , Amplichek I, Level 1, Amplichek I, Level 2, Amplichek I, Level…PMN · Traditional 05/10/2016SE
K150300Liquichek Cardiac Markers Plus Control LTJJY · Traditional 12/11/2015SE

Questions and answers

When was Variant II Hemoglobin A1C Program with Models 270-2101NU cleared by the FDA?

Variant II Hemoglobin A1C Program with Models 270-2101NU (K070452) received a 510(k) decision of Substantially Equivalent on May 7, 2007, 80 days after the submission was received.

What is the product code of K070452?

The FDA product code is LCP – Assay, Glycosylated Hemoglobin, a Class II (moderate risk) device regulated under 21 CFR 864.7470.